Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (381-390 of 409) with videos related to

Pageof 41
Sort By:
Cancer Research|December 1, 2023
Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic PlasticityDominik Awad, Pham Hong Anh Cao, Thomas L Pulliam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinomaMarkus Riester, Lillian Werner, Joaquim Bellmunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant studyMary-Ellen Taplin, Bruce Montgomery, Christopher J Logothetis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy ResistanceHimisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Blood|September 20, 2022
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growthEugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur, et al.
Cell Reports|November 21, 2019
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate CancerJustin H Hwang, Ji-Heui Seo, Michael L Beshiri, et al.
Cancer Research|June 4, 2024
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate CancerNadia Boufaied, Paolo Chetta, Tarek Hallal, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Cancer Research|June 22, 2022
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune ResponseJacob E Berchuck, Elio Adib, Sarah Abou Alaiwi, et al.
Cancer Research|February 6, 2021
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate CancerMargaret M Centenera, Julia S Scott, Jelle Machiels, et al.
Pageof 41

Showing results (381-390 of 409) with videos related to

Sort By:
Pageof 41
Cancer Research|December 1, 2023
Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic PlasticityDominik Awad, Pham Hong Anh Cao, Thomas L Pulliam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinomaMarkus Riester, Lillian Werner, Joaquim Bellmunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant studyMary-Ellen Taplin, Bruce Montgomery, Christopher J Logothetis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy ResistanceHimisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Blood|September 20, 2022
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growthEugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur, et al.
Cell Reports|November 21, 2019
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate CancerJustin H Hwang, Ji-Heui Seo, Michael L Beshiri, et al.
Cancer Research|June 4, 2024
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate CancerNadia Boufaied, Paolo Chetta, Tarek Hallal, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Cancer Research|June 22, 2022
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune ResponseJacob E Berchuck, Elio Adib, Sarah Abou Alaiwi, et al.
Cancer Research|February 6, 2021
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate CancerMargaret M Centenera, Julia S Scott, Jelle Machiels, et al.
Pageof 41